Works matching IS 03057453 AND DT 2008 AND VI 62 AND IP 4


Results: 38
    1
    2
    3
    4

    Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 4, p. 793, doi. 10.1093/jac/dkn262
    By:
    • Manuel Crespo;
    • José A. Mira;
    • Juan A. Pineda;
    • Eva Van den Eynde;
    • María J. Ríos-Villegas;
    • Antonio Collado;
    • José A. Girón-González;
    • Luis F. López-Cortés;
    • Mercedes González-Serrano;
    • Antonio Rivero;
    • Dolores Merino;
    • Juan I. Esteban
    Publication type:
    Article
    5
    6

    Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 4, p. 797
    By:
    • Claudine Duvivier;
    • Jade Ghosn;
    • Lambert Assoumou;
    • Cathia Soulié;
    • Gilles Peytavin;
    • Vincent Calvez;
    • Michèle Algarté Génin;
    • Jean-Michel Molina;
    • Olivier Bouchaud;
    • Christine Katlama;
    • Dominique Costagliola;
    • on behalf of the ANRS 121 study group
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 4, p. 852
    By:
    • Jasper van der Lugt;
    • Reshma Saskia Autar;
    • Sasiwimol Ubolyam;
    • Evian Fernandez Garcia;
    • Jongkol Sankote;
    • Anchalee Avihingsanon;
    • Theshinee Chuenyam;
    • David A. Cooper;
    • Joep Lange;
    • Praphan Phanuphak;
    • Ferdinand Wit;
    • Kiat Ruxrungtham;
    • David Burger;
    • on behalf of the HIV-NAT 019 Study Team
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 4, p. 713, doi. 10.1093/jac/dkn269
    By:
    • Mekonnen Kurabachew;
    • Stephen H. J. Lu;
    • Philipp Krastel;
    • Esther K. Schmitt;
    • Bangalore L. Suresh;
    • Anne Goh;
    • John E. Knox;
    • Ngai Ling Ma;
    • Jan Jiricek;
    • David Beer;
    • Michael Cynamon;
    • Frank Petersen;
    • Veronique Dartois;
    • Thomas Keller;
    • Thomas Dick;
    • Vasan K. Sambandamurthy
    Publication type:
    Article